FDA — authorised 29 September 1970
- Application: ANDA080001
- Marketing authorisation holder: ABBOTT
- Local brand name: CALCIUM GLUCEPTATE
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Calcium Gluceptate in United States
FDA authorised Calcium Gluceptate on 29 September 1970
Marketing authorisations
FDA — authorised 30 April 1987
- Application: ANDA089373
- Marketing authorisation holder: ABRAXIS PHARM
- Local brand name: CALCIUM GLUCEPTATE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Status: approved
FDA
- Application: NDA006470
- Marketing authorisation holder: LILLY
- Local brand name: CALCIUM GLUCEPTATE
- Indication: INJECTABLE — INJECTION
- Status: approved
Calcium Gluceptate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Calcium Gluceptate approved in United States?
Yes. FDA authorised it on 29 September 1970; FDA authorised it on 30 April 1987; FDA has authorised it.
Who is the marketing authorisation holder for Calcium Gluceptate in United States?
ABBOTT holds the US marketing authorisation.